GP practice could close after failure to warn women of risks around sodium valproate
A GP practice in London could be closed down after inspectors found that staff had failed to warn women of the risks around the epilepsy medication sodium valproate during pregnancy.
Record fines for drug companies who overcharged NHS for anti-epilepsy drug
Pfizer was fined a record £84.2m by the Competition and Markets Authority (CMA) for increasing the price of its phenytoin sodium capsules by between 2,300-2,600 per cent over night in 2012. The CMA also fined distributor Flynn Pharma £5.2 million after it accused the pair of "excessive and unfair" pricing for the vital medicine used by around 48,000 patients in the UK.
Epilepsy Society welcomes Government decision to relax licensing of medicinal cannabis
Please note that there are further updates to this news story which you can read at the links below:
Specialist doctors can now prescribe medicinal cannabis for epilepsy (1 November 2018)
Medicinal cannabis can now be prescribed by specialists for epilepsy (12 October 2018)
Protein found in worms helps to stop seizure activity
Exciting new research that involves using a protein in worms to suppress seizures, could spell hope in the future for thousands of people with epilepsy.
Epilepsy Society responds to reports of medicine stockpiling in advance of Brexit
Media reports in recent weeks have indicated that some UK pharmaceutical companies are stockpiling medicines in preparation for a possible hard Brexit in 2019.
Tribunal overrules findings in case involving epilepsy drug
A decision by the Competition and Markets Authority to fine Pfizer and Flynn Pharma a total of £90m for overcharging for an epilepsy drug, has been remitted back to the CMA after a tribunal ruled against the government watchdog's decision.